Disease Management Update
Volume III, No. 14
July 20, 2006

If this is a forwarded copy of Disease Management Update and you like what you see, you can register to receive your own copy of this complimentary service. Sign up at: http://www.hin.com/dmdesktop/diseasemanagement.html

Table of Contents

  1. Diabetes Linked to Higher Glaucoma Risk for Women
  2. Disease Management Q&A: Engaging Medicaid Clients in Disease Management Efforts
  3. Depression and Disease Management: Beyond the Stigma to Identification and Treatment
  4. Threat of Pandemic Flu Outbreak Prompts US to Help States Stockpile Antiviral Drugs
  5. ZeOmega Announces Strategic Alliance with Milliman Care Guidelines

1.) Diabetes Linked to Higher Glaucoma Risk for Women

Women with type 2 diabetes apparently run an increased risk of developing glaucoma, the eye condition characterized by increased internal pressure that can lead to blindness if left untreated. This finding comes from an analysis of data from more than 76,000 participants in the Nurses' Health Study, which is detailed in the July 2006 issue of Ophthalmology Journal. The women in the study, who were at least 40 years old and glaucoma-free when the study began in 1980, were followed until 2000. During the study period, 429 women were diagnosed with glaucoma.

To read more about this study, please visit:
http://www.ophsource.org/periodicals/ophtha/article/PIIS0161642006002971/abstract


2.) Disease Management Q&A: Engaging Medicaid Clients in Disease Management Efforts

Each week, a healthcare professional responds to a reader's query on an industry issue. This week's expert is Jerry Kiplinger, executive director, APS Healthcare:

Question: What kind of motivational interviewing techniques and other methods do you use to engage Medicaid clients in your disease management program?

Answer: "We use many different strategies to engage participants. In addition to training our health coaches in medical, technical and interpersonal skills, we teach them how to sell the program. We review marketing techniques and strategies for patient engagement. The first challenge when dealing with the Medicaid population is to figure out how to build rapport and gain client trust. This is essential in promoting behavior change. A healthy client-coach relationship affords the professional enough influence to guide the patient to make decisions to improve health and quality of life. Training is ongoing in our program, but every nurse begins with an intensive session on patient engagement."

For more strategies for serving the unique needs of the Medicaid population in disease management programs, please visit:
http://store.hin.com/product.asp?itemid=3358

We want to hear from you! Submit your question for Disease Management Q&A to info@hin.com.


3.) Depression and Disease Management: Beyond the Stigma to Identification and Treatment

With the economic burden of depression and its co-morbidities estimated at $83 billion annually–hitting employers hardest in the form of lost workdays, compromised productivity and workplace accidents–the healthcare industry is formalizing programs for early identification, adequate treatment and medical adherence of individuals with depressive disorder. This is no small task, given the challenges of screening depression severity, overcoming the stigma of mental illness and educating primary care physicians on the value of this initiative. In a recent online survey, the Healthcare Intelligence Network asked for details on current and planned initiatives for depression and disease management.

To download this complimentary white paper, please visit:
http://www.hin.com/library/registerddm.html


4.) Threat of Pandemic Flu Outbreak Prompts US to Help States Stockpile Antiviral Drugs

HHS Secretary Mike Leavitt has announced a contract award with Roche Laboratories, Inc. to provide oseltamivir phosphate (Tamiflu®) to all 50 states, the District of Columbia, five U.S. territories and the three Freely Associated States of the Pacific at a federally subsidized price. The contract will run for a period of two years with a total contract award amount of almost $150 million. "Our ultimate goal is to stockpile sufficient quantities of antiviral drugs to treat 25 percent of the U.S. population," Secretary Leavitt said. "Helping the states develop their own medical stockpiles will facilitate quicker distribution of antiviral drugs in the event of a pandemic influenza outbreak."

Read this article online at:
http://www.hhs.gov/news/press/2006pres/20060630.html


5.) ZeOmega Announces Strategic Alliance with Milliman Care Guidelines

ZeOmega, a leading provider of integrated software solutions for care management, and Milliman Care Guidelines®, a provider of evidence-based clinical guidelines, announced an agreement to integrate the evidence-based Milliman Care Guidelines® with ZeOmega's Integrated Care Management Platform, JIVA. This alliance will allow clinicians and care managers to assimilate information about a member and make decisions based on a holistic view of the member's health status.

To read more, please visit:
http://www.zeomega.com/news#Alliance_with_Milliman


Contact HIN:
For more information on the products and services available through the Healthcare Intelligence Network, contact us at (888) HIN-3530 (446-3530), (732) 528-HIN8, (528-4468), fax (732) 292-3073 or email us at info@hin.com.

All contents of this message Copyright 2006